![]() |
Name |
Integracide J
|
Molecular Formula | C39H54O7 | |
IUPAC Name* |
[(2R,3R,5R,10S,11R,12R,13R,17R)-12-acetyloxy-2,11-dihydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-3-yl] 4-hydroxybenzoate
|
|
SMILES |
C[C@H](CCC(=C)C(C)C)[C@H]1CC=C2[C@@]1([C@H]([C@@H](C3=C2CC[C@@H]4[C@@]3(C[C@H]([C@@H](C4(C)C)OC(=O)C5=CC=C(C=C5)O)O)C)O)OC(=O)C)C
|
|
InChI |
InChI=1S/C39H54O7/c1-21(2)22(3)10-11-23(4)28-17-18-29-27-16-19-31-37(6,7)34(46-36(44)25-12-14-26(41)15-13-25)30(42)20-38(31,8)32(27)33(43)35(39(28,29)9)45-24(5)40/h12-15,18,21,23,28,30-31,33-35,41-43H,3,10-11,16-17,19-20H2,1-2,4-9H3/t23-,28-,30-,31+,33-,34+,35+,38+,39-/m1/s1
|
|
InChIKey |
JYCKOXOSAKTEMU-HHBYHREBSA-N
|
|
Synonyms |
Integracide J; CHEMBL4444757
|
|
CAS | NA | |
PubChem CID | 134692985 | |
ChEMBL ID | CHEMBL4444757 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 634.8 | ALogp: | 7.5 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 113.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 46 | QED Weighted: | 0.202 |
Caco-2 Permeability: | -5.23 | MDCK Permeability: | 0.00001420 |
Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0.322 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.049 |
30% Bioavailability (F30%): | 0.524 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 99.20% |
Volume Distribution (VD): | 1.821 | Fu: | 3.35% |
CYP1A2-inhibitor: | 0.08 | CYP1A2-substrate: | 0.111 |
CYP2C19-inhibitor: | 0.229 | CYP2C19-substrate: | 0.31 |
CYP2C9-inhibitor: | 0.385 | CYP2C9-substrate: | 0.934 |
CYP2D6-inhibitor: | 0.861 | CYP2D6-substrate: | 0.099 |
CYP3A4-inhibitor: | 0.77 | CYP3A4-substrate: | 0.649 |
Clearance (CL): | 3.285 | Half-life (T1/2): | 0.572 |
hERG Blockers: | 0.209 | Human Hepatotoxicity (H-HT): | 0.415 |
Drug-inuced Liver Injury (DILI): | 0.398 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.079 | Maximum Recommended Daily Dose: | 0.912 |
Skin Sensitization: | 0.331 | Carcinogencity: | 0.008 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.914 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003755 | ![]() |
0.783 | D0O5WP | ![]() |
0.307 | ||
ENC001119 | ![]() |
0.721 | D02HSB | ![]() |
0.281 | ||
ENC003486 | ![]() |
0.721 | D0C4RB | ![]() |
0.277 | ||
ENC003485 | ![]() |
0.664 | D0X7XG | ![]() |
0.267 | ||
ENC002075 | ![]() |
0.346 | D0H2MO | ![]() |
0.266 | ||
ENC005630 | ![]() |
0.325 | D0Q0PR | ![]() |
0.240 | ||
ENC002718 | ![]() |
0.296 | D06CWH | ![]() |
0.239 | ||
ENC003259 | ![]() |
0.294 | D0N0RU | ![]() |
0.236 | ||
ENC001603 | ![]() |
0.291 | D09WYX | ![]() |
0.233 | ||
ENC005968 | ![]() |
0.291 | D03ZTE | ![]() |
0.226 |